4 stories mentioning LUpdated 29d ago
Every FINWIRES story that references L, newest first.
Dino Robusto, Director, on May 29, 2026, executed a purchase for 5,000 shares in Loews (L) for $523,700. Following the Form 4 filing with the SEC, Robusto has control over a total of 10,235 common shares of the company, with 10,235 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/60086/000134888926000008/xslF345X05/wk-form4_1780318742.xml
Loews Keeps Quarterly Dividend at $0.0625 per Share, Payable June 9 to Holders of Record May 27
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target to CAD69 from CAD74, representing ~24x our 2027 EPS of CAD2.88 (lowered from CAD2.95; 2026 EPS lowered to CAD2.61 from CAD2.66). This multiple represents a premium to the company's five-year average forward P/E of 18x, though we note L traded above 20x in the early 2000s. We believe this premium is justified given strong top- and bottom-line growth. Additionally, L has accelerated new store openings (both food and drug retail) in recent years, which should increasingly contribute to revenue as these locations mature. The current earnings headwind from the East Gwillimbury distribution center ramp should ease later this year, though a similar drag is likely as the new Caledon distribution center ramps in 2027. Nevertheless, L is positioned to deliver impressive high-single digit EPS growth over the next few years. We also anticipate a sizable share buyback following the PC Financial sale closure in Q3.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:L's Q1 revenue of CAD14.4B (+4% Y/Y) missed consensus by CAD90M, while adjusted EPS of CAD0.49 (+9% Y/Y) fell short of CAD0.52 estimates, though we think PC Financial's presentation in discontinued operations may affect comparability. Food retail same-store sales of 2.4% accelerated from Q4's 1.5%, with drug retail posting 4.1% growth. We view the solid same-store sales momentum as encouraging, particularly given internal food inflation remained well below the 4.4% CPI, indicating L's strong value proposition. Management reiterated 2026 guidance for high single-digit EPS growth and CAD2.4B in gross capex. Store expansion accelerated with 13 net openings, including five hard discount locations, aligning with consumer preference shifts toward value formats. Strong FCF of CAD621M (+189% Y/Y) supported aggressive share repurchases of CAD648M. We believe the pending PC Financial divestiture in Q3 2026 will simplify operations and provide additional capital flexibility for core retail growth.
